Narcolepsy in children and young people in Ireland: 2006-2017
Irwin Gill1, Aishling Sheils2, Elaine Reade3
1Department of Neurodisability, Children's Health Ireland, Temple Street, Dublin, Ireland.
Insights
Most young people in Ireland diagnosed with narcolepsy after the Pandemrix vaccine experienced cataplexy and obesity. Treatment challenges were noted, though sodium oxybate improved obesity metrics.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Narcolepsy in young people is a significant health concern.
- The Pandemrix vaccine has been linked to narcolepsy onset.
- Understanding the characteristics of pediatric narcolepsy is crucial for management.
Purpose of the Study:
- To characterize young individuals diagnosed with narcolepsy in Ireland.
- To investigate the association with Pandemrix vaccine exposure.
- To describe symptomatology, diagnostic findings, and treatment outcomes.
Main Methods:
- Retrospective medical record review at Ireland's national tertiary referral center for pediatric narcolepsy.
- Analysis of vaccine exposure, clinical symptoms, hypocretin levels, HLA DQB1*0602 status, and MRI findings.
- Evaluation of treatment responses, including medication use and body mass index (BMI) changes.
Main Results:
- Sixty-seven patients diagnosed between 2006-2017; 91% received the Pandemrix vaccine prior to symptom onset.
- High prevalence of cataplexy (77.6%), low hypocretin (87.5%), high HLA DQB1*0602 positivity (95%), and obesity.
- Treatment challenges were common, with 76.1% requiring multiple medications; sodium oxybate improved BMI and obesity scores.
Conclusions:
- Narcolepsy in Irish youth imposes a substantial burden on education, physical, and mental health.
- Symptoms can be resistant to medical treatment, highlighting the need for specialized care.
- Prompt referral to tertiary centers for multidisciplinary management is essential for optimal outcomes.
Aim:
To describe the population of young people in Ireland diagnosed with narcolepsy with regards to vaccine exposure, symptomatology, investigation results and experience of medical treatment.
Method:
Retrospective review of medical records at the single tertiary referral centre for young people with narcolepsy in Ireland.
Results:
Sixty-seven patients were diagnosed with narcolepsy between July 2006 and July 2017. Sixty-one (91%) of these developed symptoms after receiving the Pandemrix vaccine. The population was largely homogeneous with low hypocretin (87.5%), HLA DQB1∗0602 positivity (95%) and unremarkable findings on MRI Brain (100%). 77.6% experienced cataplexy; we also measured high levels of obesity, school non-attendance and psychosocial complexity. Symptoms often continued despite treatment, with multiple medications prescribed in 76.1% of patients. Prescription of sodium oxybate was associated with a significant reduction in BMI standard deviation scores at 6 months, with improved IOTF obesity scores seen at 36 month follow-up.
Conclusions:
This paper describes the experience of narcolepsy in children and young people in Ireland from 2006 - 2017 at the national tertiary referral centre. Narcolepsy in children and young people in Ireland carries a significant burden of illness, with impact on participation in education as well as physical and mental health. Symptoms can be refractory to medical treatment. Referral to tertiary centres for prompt treatment and multidisciplinary input is essential.
Related Concept Videos
Narcolepsy
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia
Nightmares and Night Terrors
Nightmares...


